Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Soukop

Showing results (81-90 of 102) with videos related to

Pageof 11
Sort By:
European Journal of Cancer & Clinical Oncology|August 1, 1983
A randomised multicentre single blind comparison of a cannabinoid anti-emetic (levonantradol) with chlorpromazine in patients receiving their first cytotoxic chemotherapyA W Hutcheon, J B Palmer, M Soukop, et al.
British Journal of Cancer|November 1, 1988
Pharmacokinetics and anti-emetic efficacy of BRL43694, a new selective 5HT-3 antagonistJ Cassidy, V Raina, C Lewis, et al.
Journal of Clinical Pathology|March 1, 1985
Functional and structural changes of the human proximal small intestine after cytotoxic therapyD Cunningham, R J Morgan, P R Mills, et al.
British Journal of Cancer|March 27, 2001
A phase II trial of bryostatin 1 in patients with non-Hodgkin's lymphomaF H Blackhall, M Ranson, J A Radford, et al.
Biochimica Et Biophysica Acta|October 4, 1984
Low-density lipoprotein metabolism in mice with soft tissue tumoursS A Hynds, J Welsh, J M Stewart, et al.
Cancer Research|December 15, 1987
Phase I and pharmacokinetic study of flavone acetic acidD J Kerr, S B Kaye, J Cassidy, et al.
Lancet (London, England)|August 24, 1991
Comparison of dexamethasone and ondansetron in the prophylaxis of emesis induced by moderately emetogenic chemotherapyA L Jones, A S Hill, M Soukop, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1987
Mitoxantrone versus doxorubicin in combination chemotherapy for advanced carcinoma of the breastR C Leonard, M A Cornbleet, S B Kaye, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1994
Quinidine as a resistance modulator of epirubicin in advanced breast cancer: mature results of a placebo-controlled randomized trialG C Wishart, D Bissett, J Paul, et al.
Medical Oncology and Tumor Pharmacotherapy|January 1, 1986
TNO-6 has no effect in gastrointestinal cancer: N-acetyl-glucosaminidase shows renal damageD Cunningham, M Soukop, N L Gilchrist, et al.
Pageof 11

Showing results (81-90 of 102) with videos related to

Sort By:
Pageof 11
European Journal of Cancer & Clinical Oncology|August 1, 1983
A randomised multicentre single blind comparison of a cannabinoid anti-emetic (levonantradol) with chlorpromazine in patients receiving their first cytotoxic chemotherapyA W Hutcheon, J B Palmer, M Soukop, et al.
British Journal of Cancer|November 1, 1988
Pharmacokinetics and anti-emetic efficacy of BRL43694, a new selective 5HT-3 antagonistJ Cassidy, V Raina, C Lewis, et al.
Journal of Clinical Pathology|March 1, 1985
Functional and structural changes of the human proximal small intestine after cytotoxic therapyD Cunningham, R J Morgan, P R Mills, et al.
British Journal of Cancer|March 27, 2001
A phase II trial of bryostatin 1 in patients with non-Hodgkin's lymphomaF H Blackhall, M Ranson, J A Radford, et al.
Biochimica Et Biophysica Acta|October 4, 1984
Low-density lipoprotein metabolism in mice with soft tissue tumoursS A Hynds, J Welsh, J M Stewart, et al.
Cancer Research|December 15, 1987
Phase I and pharmacokinetic study of flavone acetic acidD J Kerr, S B Kaye, J Cassidy, et al.
Lancet (London, England)|August 24, 1991
Comparison of dexamethasone and ondansetron in the prophylaxis of emesis induced by moderately emetogenic chemotherapyA L Jones, A S Hill, M Soukop, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1987
Mitoxantrone versus doxorubicin in combination chemotherapy for advanced carcinoma of the breastR C Leonard, M A Cornbleet, S B Kaye, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1994
Quinidine as a resistance modulator of epirubicin in advanced breast cancer: mature results of a placebo-controlled randomized trialG C Wishart, D Bissett, J Paul, et al.
Medical Oncology and Tumor Pharmacotherapy|January 1, 1986
TNO-6 has no effect in gastrointestinal cancer: N-acetyl-glucosaminidase shows renal damageD Cunningham, M Soukop, N L Gilchrist, et al.
Pageof 11